NRL994 not checked

Norgine

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
1 active
2 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“In the afternoon/evening before colonoscopy: 1 litre solution plus 0.5 litre clear fluid. Day of colonoscopy: 1 litre solution plus at least up to 1 litre clear liquid.”In the company’s words, NCT06597903 on ClinicalTrials.gov
Tested for
Colorectal Cancer
Main trialPhase 2
“A first study at one centre, with a new oral gut cleansing solution, NRL994, in patients who were going to have a colonoscopy. The study was to find out how well the new "Low Dose Bowel Prep" (LDBP) worked, and whether it was safe to use.”In the company’s words, NCT06597903 on ClinicalTrials.gov
Other names
MOVIPREP

Other drugs for Colorectal Cancer

All 392 drugs for Colorectal Cancer

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Completed Mar 2002 A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution
Phase 3/4Authorised not given Clinical trial on the assessment of mucosal visualization quality and diagnostic performance in small bowel capsule endoscopy using different preparation protocols
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow NRL994

Following is part of Solo: you see every change to NRL994 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in